Advances in dendritic-cell-based therapeutic vaccines for cervical cancer. - Wikidata - wikimedia - TriplyDB

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

http://www.wikidata.org/entity/Q36974722

about

HPV in oropharyngeal cancer: the basics to know in clinical practice Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens.Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.Treatment options in recurrent cervical cancer (Review).A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice.Human papillomavirus vaccines in plants.Cell-mediated immune response: a clinical review of the therapeutic potential of human papillomavirus vaccination.Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells.

P2860

Q26853669-36704672-2CD0-4293-B029-D08BDCC307C0 Q28652354-0D5F71E8-119A-42D7-B900-9B57B1CAB7F3 Q34757171-42F3699A-D18F-45C9-85AF-14075D82EEC5 Q35405204-3512F154-5F2A-4D68-8F65-7273975703D9 Q36216582-EE503E7B-DD79-4023-AEDB-26C81F073DEB Q37079131-DDF14A09-AC62-4A5C-AF5B-857DC8066B2E Q37776720-9CE7130A-4E7F-425C-8D4E-4F741DA53777 Q38242083-619ECCA8-3B7E-492A-A969-AEBB069BAD94 Q39330979-A74BAC97-EF1E-4660-ABD5-5577B1F4B6F7 Q39751992-68294B9C-81C2-40B5-A547-EDFF3EFED24A

P2860

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

http://www.wikidata.org/entity/Q36974722

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

@en

type

label

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

@en

prefLabel

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

@en

P1433

Q36974722-DA13CC1D-8307-4300-AFD9-8B0BF5D63EAA

P1476

Q36974722-FD50E34C-5175-43C8-A884-488A49389E67

P2093

Q36974722-0AEF1129-2D78-4774-9B49-ABE8E785A0AF

Q36974722-4B0A6833-FFE4-4A49-B034-11CCDABF01B9

Q36974722-967AA4D6-F01F-46C5-A996-7CD643488779

Q36974722-A45DF376-DCC5-4363-9AC9-34B58A960671

P2860

Q36974722-003348CE-AEC0-4E94-A6BE-7968DC5917D3

Q36974722-017CBD4A-C4BA-4865-8872-001000A984BA

Q36974722-01ABB44C-C3C9-4151-8EC4-6A684E177BCC

Q36974722-041A542E-585B-47BD-B018-A71A26DE2829

Q36974722-060A0D76-6C88-4EE4-9DAA-2C6740981C5B

Q36974722-0A362A52-EF46-49CF-B956-0C77959F3C8E

Q36974722-0DB94EB4-D86F-4A20-988C-24CBF8B6DB2E

Q36974722-1568BDC5-CDBC-4DBC-8606-8FC4BB636E14

Q36974722-1592F096-607C-4A21-A623-E5374BA6F28E

Q36974722-1F96FD19-5E24-4EAC-B89A-3DE725BD3FB5

P304

Q36974722-101C7FB0-D639-4E62-922C-4D16264B9F11

P31

Q36974722-70E1C723-3D35-4739-9DAB-73FC4DE72B4D

P356

Q36974722-76D69B6A-D044-48A3-9B77-36D756495BEE

P433

Q36974722-F8256F76-1283-4991-A42C-014E016C4FBE

P478

Q36974722-8D1C1FC3-543C-4945-91D9-3BEFC1E7451F

P577

Q36974722-21391B56-790E-45CE-8473-014734530C6A

P698

Q36974722-B0AA5DB1-CA26-47B9-A42E-8BB075C71B28

P356

14737140.7.10.1473

P1433

Expert Review of Anticancer Therapy

P1476

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

@en

P2093

Alessandro D Santin

http://www.w3.org/2001/XMLSchema#string

Martin J Cannon

http://www.w3.org/2001/XMLSchema#string

Sergio Pecorelli

http://www.w3.org/2001/XMLSchema#string

Stefania Bellone

http://www.w3.org/2001/XMLSchema#string

P2860

The causal relation between human papillomavirus and cervical cancer.

Dendritic cells and the control of immunity

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Cancer statistics, 2006

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

P304

1473-1486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.7.10.1473

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17944571

http://www.w3.org/2001/XMLSchema#string